FFCP PHASE1:Hg19::chr14:106355978..106355991,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=9834 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC=19955 | |||
|TSSclassifier=strong | |||
|UniProt=Q05DB7 | |||
|association_with_transcript=0bp_to_uc001ysq.2,uc001ysr.2_5end | |||
|cluster_id=chr14:106355978..106355991,+ | |||
|coexpression_cluster_id=C2282 | |||
|description=CAGE_peak_1_at_KIAA0125_5end | |||
|id=chr14:106355978..106355991,+ | |||
|ontology_enrichment_celltype=CL:0000037!3.94e-18!172;CL:0000566!3.94e-18!172;CL:0000988!7.48e-17!182;CL:0002032!8.57e-16!165;CL:0000837!8.57e-16!165;CL:0000763!8.85e-12!112;CL:0000049!8.85e-12!112;CL:0001024!1.54e-07!1;CL:0000236!7.53e-07!14 | |||
|ontology_enrichment_celltype_v019=CL:0000037;2.07e-11;1!CL:0001024;2.07e-11;1!CL:0000763;2.17e-10;100 | |||
|ontology_enrichment_celltype_v019_2=CL:0000763,9.87e-16,108;CL:0000049,9.87e-16,108;CL:0000037,1.50e-14,168;CL:0000988,1.10e-13,177;CL:0002032,2.47e-13,161;CL:0000837,2.47e-13,161;CL:0001024,1.78e-11,1 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:1240!2.86e-41!39;DOID:8692!6.78e-41!31;DOID:2531!1.04e-30!51;DOID:0060083!1.04e-30!51;DOID:0050686!4.36e-09!137;DOID:8552!2.67e-07!1;DOID:1036!2.78e-07!8;DOID:9119!2.84e-07!1 | |||
|ontology_enrichment_disease_v019=DOID:8692;2.51e-57;31!DOID:1240;9.02e-43;39!DOID:2531;1.43e-29;51!DOID:0060083;1.43e-29;51!DOID:9119;4.67e-11;1!DOID:8552;4.67e-11;1 | |||
|ontology_enrichment_disease_v019_2=DOID:8692,1.76e-60,31;DOID:1240,4.75e-55,39;DOID:2531,1.31e-41,51;DOID:0060083,1.31e-41,51;DOID:0050686,5.72e-14,137;DOID:8552,4.44e-11,1;DOID:9119,4.91e-11,1;DOID:162,3.54e-07,235;DOID:14566,5.61e-07,239 | |||
|ontology_enrichment_uberon=UBERON:0004177!9.89e-08!7;UBERON:0002372!6.57e-07!1;UBERON:0001961!6.57e-07!1;UBERON:0001744!6.57e-07!1;UBERON:0001735!6.57e-07!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.81680571135301,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.320929027076094,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.546138611262131,0,0.426730222566507,0,0,0.661044872784862,0,0,1.76171156811282,0,7.93027971474155,4.48406850385229,1.05353633910031,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.371457501329565,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.088048434013226,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159426272728822,3.19326994292507,5.93666647410337,3.17510374085824,0,3.36956613736151,0,0,2.50634477090067,19.9764297805892,0,0,0,0,0,0,0,0,1.67043704337145,1.23087398947712,4.8682022125677,1.33228787199128,4.22961015263549,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.615424027305347,0,0,0,0,0.0986434056369336,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.66866435871542,1.49590513710141,0,0,0,0,2.38404868470568,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,11.0412688797312,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.82092520749339,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0939839179798536,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0645889098360061,0.0620747142958579,0,0,0,0,0,0.0673520530145875,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@KIAA0125 | |||
}} |
Latest revision as of 21:41, 18 September 2015
Short description: | p1@KIAA0125 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_KIAA0125_5end |
Coexpression cluster: | C2282_acute_CD133_CD34_granulocyte_hairy_chronic_CD19 |
Association with transcript: | 0bp_to_uc001ysq.2, uc001ysr.2_5end |
EntrezGene: | KIAA0125 |
HGNC: | 19955 |
UniProt: | Q05DB7 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
myeloid cell | 9.87e-16 | 108 |
common myeloid progenitor | 9.87e-16 | 108 |
hematopoietic stem cell | 1.50e-14 | 168 |
hematopoietic cell | 1.10e-13 | 177 |
hematopoietic oligopotent progenitor cell | 2.47e-13 | 161 |
hematopoietic multipotent progenitor cell | 2.47e-13 | 161 |
CD34-positive, CD38-negative hematopoietic stem cell | 1.78e-11 | 1 |
Ontology term | p-value | n |
---|---|---|
myeloid leukemia | 1.76e-60 | 31 |
leukemia | 4.75e-55 | 39 |
hematologic cancer | 1.31e-41 | 51 |
immune system cancer | 1.31e-41 | 51 |
organ system cancer | 5.72e-14 | 137 |
chronic myeloid leukemia | 4.44e-11 | 1 |
acute myeloid leukemia | 4.91e-11 | 1 |
cancer | 3.54e-07 | 235 |
disease of cellular proliferation | 5.61e-07 | 239 |